share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

Recursion Pharmaceuticals | 4:持股變動聲明-董事 Li Dean Y
美股SEC公告 ·  10/04 18:34
Moomoo AI 已提取核心訊息
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a transaction on 10/01/2024 involving the grant of 1,925 shares of Class A Common Stock at no cost. Following this transaction, Li directly holds a total of 75,703 shares. Additionally, Li has indirect ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a transaction on 10/01/2024 involving the grant of 1,925 shares of Class A Common Stock at no cost. Following this transaction, Li directly holds a total of 75,703 shares. Additionally, Li has indirect ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
與Recursion Pharmaceuticals, Inc. [RXRX]相關的Dean Y. Li於2024年10/01完成了一筆交易,涉及免費授予1,925股A類普通股。在這筆交易之後,Li直接持有總共75,703股股票。此外,Li通過各種信託間接擁有3,112,844股股票,包括Dean Li和Ruth Li可撤銷信託,Dean Y. Li GRAt和Dean Y. Li 2021家庭信託。
與Recursion Pharmaceuticals, Inc. [RXRX]相關的Dean Y. Li於2024年10/01完成了一筆交易,涉及免費授予1,925股A類普通股。在這筆交易之後,Li直接持有總共75,703股股票。此外,Li通過各種信託間接擁有3,112,844股股票,包括Dean Li和Ruth Li可撤銷信託,Dean Y. Li GRAt和Dean Y. Li 2021家庭信託。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息